Sector
PharmaceuticalsOpen
₹12.25Prev. Close
₹12.22Turnover(Lac.)
₹20.73Day's High
₹12.5Day's Low
₹12.0152 Week's High
₹2952 Week's Low
₹11.15Book Value
₹7.87Face Value
₹1Mkt Cap (₹ Cr.)
282.26P/E
20.02EPS
0.62Divi. Yield
06 Sep 2024
12:00 AM
BookCloser
6 Sep 2024
12:00 AM
AGM
Announcement Date: 06 Sep, 2024
4 Jun 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 28.46 | 18.02 | 12.65 | 12.65 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 142.3 | 61 | 31.35 | 27.24 |
Net Worth | 170.76 | 79.02 | 44 | 39.89 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 59.64 | 55.61 | 55.8 | 43.77 |
yoy growth (%) | 7.24 | -0.33 | 27.46 | 4.46 |
Raw materials | -35.71 | -33.62 | -32.69 | -26.73 |
As % of sales | 59.88 | 60.44 | 58.59 | 61.06 |
Employee costs | -7.2 | -6.81 | -6.12 | -5.54 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 5.43 | 2.43 | 3.02 | 1.44 |
Depreciation | -0.88 | -1 | -0.98 | -0.92 |
Tax paid | -1.02 | -0.69 | -0.8 | -0.61 |
Working capital | 6.89 | 2.82 | 4.16 | -0.74 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 7.24 | -0.33 | 27.46 | 4.46 |
Op profit growth | 101.2 | -19.28 | 83.47 | -51.56 |
EBIT growth | 93.42 | -16.42 | 75.72 | -42.87 |
Net profit growth | 117.53 | -16.4 | 165.71 | -69.09 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 137.9 | 86.71 | 65.6 | 61.21 | 59.65 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 137.9 | 86.71 | 65.6 | 61.21 | 59.65 |
Other Operating Income | 10.43 | 4.91 | 3.95 | 1.38 | 0.52 |
Other Income | 0 | 0 | 0 | 0 | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Arihant Baid
Independent Director
A S Nageswar Rao
Non Executive Director
A Ranga Rao Pantulu
Non Executive Director
S Ch Dharma Rao
Independent Director
Dilip Raj Singhvi
Independent Director
Shilpa Bung
Company Sec. & Compli. Officer
Dinesh Kumar Kejriwal.
Survey No 133 Bollaram,
Jinnaram Mandal,
Telangana - 502325
Tel: 91-8458-279406/279516
Website: http://www.gennexlab.com
Email: investorrelations@gennexlab.com
60A & 60B,
Chowringhee Road, 2nd Floor,
Kolkata - 700 020
Tel: 91-33-22800900
Website: -
Email: -
Summary
Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) was incorporated on June 25, 1985. The Company got converted into a Public Limited Company and the name was changed from Prude...
Read More
Reports by Gennex Laboratories Ltd
What is the Gennex Laboratories Ltd share price today?
What is the Market Cap of Gennex Laboratories Ltd?
What is the PE and PB ratio of Gennex Laboratories Ltd?
What is the 52 Week High and Low of Gennex Laboratories Ltd?
What is the CAGR of Gennex Laboratories Ltd?
What is the shareholding pattern of Gennex Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.